Update and evaluation of Australian guidelines. Government perspective.
Mitchell
A
A
Pharmaceutical Evaluation, Department of Health and Family Services, Canberra, Australia.
D001315:Australia; D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical / Q000331:legislation & jurisprudence / Q000639:trends*; D005569:Formularies as Topic; D017408:Guidelines as Topic; D006801:Humans; D010043:Outcome and Process Assessment, Health Care